
Palvella Therapeutics to Present Key Findings on Lymphatic Malformations at Dermatology Conference
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced that an abstract presenting groundbreaking data on the prevalence and annual incidence of lymphatic malformations (LMs) in the U.S. has been …
Palvella Therapeutics to Present Key Findings on Lymphatic Malformations at Dermatology Conference Read More